BlockRx is a series of initiatives by iSolve which leverage the Blockchain and iSolve’s Advanced Digital Ledger Technology™ (ADLT™). The platform is a comprehensive solution to fully integrate Life Science Researchers, BioPharma, Medical Device Manufactures, and Healthcare Providers to improve Patient Outcomes.

Invest with AMFEIX

Featured Video

BlockRx Details

Team Location Pennsylvania, USA
First Announced July 10, 2017

BlockRx Technical Details

Blockchain Ethereum (ERC20)
Consensus Proof of Stake (PoS)

BKRx Network & Signals

Powered by

BKRx Sentiment

ICO Details

Status | Crowdsale Ended
Whitelist Registration
ICO Start Date Oct 13, 2017 | 10:00 am UTC
ICO End Date Jan 31, 2018 | 11:00 pm UTC
Soft Cap no soft cap
Hard Cap $300,000,000 USD
Contribution Size Min: 1 ETH
Total Supply 300,000,000 BKRx
Investor Supply 120,000,000 BKRx
ICO Conversion

1 ETH = 187 BKRx
(Oct 13- Nov 2)
1 ETH = 170 BKRx
(Nov 3- Dec 2)
1 ETH = 150 BKRx
(Dec 3- Jan 2)
1 ETH = 130 BKRx
(Jan 3- Jan 31)

Supply Distribution

40% ICO Crowdsale
30% Founders and Charity Distribution
20% Reserve fund for Pharma Companies (not exchangeable)
10% Future employee benefits

BlockRx Team

Gordon Tampol
Gordon Tampol

Chief Executive Officer

Darryl G Glover
Darryl G Glover

Chief Clinical Officer

Kasia Piskorska
Kasia Piskorska

Chief Financial Officer

Carlos Sanchez
Carlos Sanchez

Chief Technology Officer